The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

OXP OXFORD PHARMASCIENCE GROUP PLC ORD 0.1P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 12-Aug-2015 OXP Preliminary PK Data & Initiation of Further Study RNS -4.49% Down
07:00 31-Jul-2015 OXP Results from Pilot Clinical Study of OXP500 RNS -14.13% Down
07:00 16-Jul-2015 OXP Initiation of Pilot Clinical Study RNS -10.36% Down
07:00 16-Jul-2015 OXP Initiation of Pilot Clinical Study for Ibuprofen RNS -10.36% Down
12:07 06-Jul-2015 OXP Holding(s) in Company RNS -4.79% Down
14:57 30-Jun-2015 OXP Holding(s) in Company RNS -7.18% Down
11:21 30-Jun-2015 OXP Holding(s) in Company RNS -7.18% Down
11:02 30-Jun-2015 OXP Holding(s) in Company RNS -7.18% Down
11:02 30-Jun-2015 OXP Holding(s) in Company RNS -7.18% Down
16:02 29-Jun-2015 OXP Holding(s) in Company RNS -8.75% Down
14:13 29-Jun-2015 OXP Holding(s) in Company RNS -8.75% Down
15:37 24-Jun-2015 OXP Result of GM RNS -2.33% Down
07:00 09-Jun-2015 OXP Posting of Circular and Notice of GM RNS +1.26% Up
08:20 03-Jun-2015 OXP Grant of Share Options RNS +1.69% Up
07:00 02-Jun-2015 OXP Proposed Placing RNS +0.21% Up
07:00 18-May-2015 OXP Initiation of Pilot Clinical Study for Naproxen RNS +9.65% Up
07:22 15-May-2015 OXP Ibuprofen progressing to proof of concept trial RNS +5.65% Up
07:00 13-May-2015 OXP PK Results for OXPzero Naproxen vs. Naprosyn RNS -3.58% Down
17:21 15-Apr-2015 OXP Holding(s) in Company RNS +13.02% Up
07:00 27-Mar-2015 OXP Successful Pilot Clinical Study RNS +8.95% Up

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address Weston House, Bradgate Park View, Chellaston, Derby, DE73 5UJ, United Kingdom
Company website http://www.oxfordpharma...
Market cap(in millions)* £ 96.45
Listing/Admission to trading 12 Feb 2010
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
30-Aug-15
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 75,000
SEDOL B3LXPB4
ISIN number GB00B3LXPB43



OXFORD PHARM GP share - news analysis